RecruitingPhase 3NCT04689152

Clinical Trial to Evaluate the Efficacy and Safety of Cellgram-LC Administration in Patients With Alcoholic Cirrhosis

A Multicenter, Randomized, Open-label Phase III Clinical Trial to Evaluate Efficacy and Safety of the Cellgram-LC in Patients With Alcoholic Liver Cirrhosis

Sponsor

Pharmicell Co., Ltd.

Enrollment

200 participants

Start Date

Mar 2, 2021

Study Type

INTERVENTIONAL

Conditions

Alcoholic Cirrhosis

Summary

This phase III clinical trial is designed to evaluate the efficacy and safety of autologous Mesenchymal Stem Cells (MSC) injected hepatic artery.

Eligibility

Min Age: 20 YearsMax Age: 71 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Cellgram-LC for people with alcoholic cirrhosis. The study is currently recruiting participants at 11 locations. People eligible for this study include aged 20 Years to 71 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALCellgram-LC

Patients will receive single injection of Cellgram-LC(mesenchymal stem cell) hepatic artery.

Locations(11)

Soonchunhyang University Hospital

Bucheon-si, South Korea

Soonchunhyang University Hospital

Cheonan, South Korea

Gangwon National University Hospital

Chuncheon, South Korea

Hallym Univ. Medical Center

Chuncheon, South Korea

Gangneung Asan Hospital

Gangneung-si, South Korea

Eunpyeong St. Mary's Hospital

Seoul, South Korea

Korea University Anam Hospital

Seoul, South Korea

Seoul National University Hospital

Seoul, South Korea

Soonchunhyang University Hospital

Seoul, South Korea

Wonju Severance Christian Hospital

Wŏnju, South Korea

Yongin Severance Hospital

Yongin, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04689152

Related Trials

Study of Genetic Determinants in Alcoholic Hepatitis and Establishment of a Multicenter Prospective Cohort of Patients With Alcoholic Liver Disease

NCT041065189 locations

SAMe Trial for Patients With Alcoholic Cirrhosis

NCT042502592 locations

Optimized Remission in Alcohol-related Liver Cirrhosis

NCT068664961 location

Long-term Follow-up of Patients With Alcoholic Liver Cirrhosis Who Had Administered Cellgram-LC in PMC-P-07 Study

NCT0509388111 locations